Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome.
Clinical trial NCT07090889 · RECRUITING
Trial details
- NCT number
- NCT07090889
- Sponsor
- Orvida Pharma (formerly Kamari Pharma)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-08
- Primary completion
- 2026-11-21
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.